Recipharm Venture Fund
VC Fund
Recipharm Venture Fund is a VC fund focused on Biotechnology and Medical. Recipharm Venture Fund is part of Recipharm AB.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Recipharm Venture Fund invests in
Stages Recipharm Venture Fund invests in
Countries Recipharm Venture Fund invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Medical 1 (50%)
- Health Care 1 (50%)
- Life Science 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Series A 1 (50%)
- Venture - Series Unknown 1 (50%)
Country
- Sweden 1 (50%)
- Switzerland 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
NewBiologix
|
NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines. | $50.3M / Series A / May 11, 2023 | |
Cinclus Pharma
|
Cinclus Pharma AG is a research based biotech company developing small molecules for the treatment of gastric acid related diseases. Their main asset, X842, has been studied in a Phase I clinical trial. Cinclus Pharma is based in Basel, Switzerland. | $26.4M / Venture - Series Unknown / Mar 04, 2020 |
Co-Investors
Fourth Swedish National Pension Fund
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Recipharm Venture Fund invest in?
Recipharm Venture Fund invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Recipharm Venture Fund last invest?
The most recent investment recorded for Recipharm Venture Fund closed in May 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
